Published • loading... • Updated
Thubrikar Aortic Valve partners with MAC’s MEDICAL Group and expands the TAVI-1 CE Mark trial of the Optimum TAVI System™
Summary by HealthTech HotSpot
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Thubrikar Aortic Valve partners with MAC’s MEDICAL Group and expands the TAVI-1 CE Mark trial of the Optimum TAVI System™
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--#TAVI--Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC’s CEO, Ante Cicin-Sain. As part of the exclusive distribution rights agreement for Europe, Mr. Cicin-Sain, MAC’s MEDICAL Group, and their affiliates will co-participate in financing up to 50 implants toward the CE more... The post Thubrikar Aortic Valve partne…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
